Aklog Lishan 4
4 · PAVmed Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
PAVmed Inc.PAVM
Aklog Lishan
DirectorChairman and CEO
Transactions
- Award
Common Stock
2025-09-30+150,000→ 228,418 total
Holdings
- 1,333(indirect: By LLC)
Common Stock
- 154(indirect: By daughter)
Common Stock
- 152(indirect: By son)
Common Stock
- 297,105(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
- [F2]Dr. Aklog is a member and sole manager of Pavilion Venture Partners LLC, and therefore has sole voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.
- [F3]Dr. Aklog is a co-manager of HCFP/AG LLC, and therefore has joint voting and dispositive power over the securities held by this entity. Dr. Aklog disclaims beneficial ownership of securities held by this entity, except to the extent of his proportionate pecuniary interest therein.